Literature DB >> 12381336

Percutaneous endoscopic gastrostomy (PEG): change in practice since 1988.

R H Skelly1, R M Kupfer, M E Metcalfe, S P Allison, M Holt, M A Hull, J K Rawlings.   

Abstract

BACKGROUND AND AIMS: We previously reported a 30-day mortality following percutaneous endoscopic gastrostomy (PEG) of 8% (1988-92). Concerns over increasing mortality rates prompted us to survey current practice compared with 1988-92: assess case mix, outcome, risk factors for early death, and review practice guidelines.
METHODS: 78 consecutive adults were referred for PEG over 7 months. Baseline characteristics, including age and functional status (Barthel Index), and outcome at 30 and 180 days were prospectively evaluated.
RESULTS: 74 patients. Median age 69 years; male 55%. Major underlying diagnoses: cerebrovascular disease 42%, head and neck tumours 19%, motor neurone disease 4% (33%, 16% and 27% in 1988-92). Mortality rates at 30, 90 and 180 days were 19%, 35% and 42% respectively (8%, 20% and 37% in 1988-92). Univariate analysis showed that age >75 years, Barthel Index <1 and Glasgow Coma Scale < or =10 were significant risk factors for death at 30 days: odds ratios (95% confidence intervals) 3.9 (1.1-13), 5.9 (1.4-25) and 4.4 (1.2-15) respectively.
CONCLUSIONS: 30-day mortality was increased from 8% to 19% between 1988-92 and 1998-99 reflecting a change in referral patterns: more elderly with cerebrovascular disease and fewer with motor neurone disease. Age and functional status should be considered when advising on PEG feeding.

Entities:  

Mesh:

Year:  2002        PMID: 12381336     DOI: 10.1054/clnu.2002.0563

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  5 in total

Review 1.  Percutaneous endoscopic gastrostomy: a safe and effective bridge for enteral nutrition in neurological or non-neurological conditions.

Authors:  Rasim Gencosmanoglu
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  Complication rate lower after percutaneous endoscopic gastrostomy than after surgical gastrostomy: a prospective, randomized trial.

Authors:  M Ljungdahl; M Sundbom
Journal:  Surg Endosc       Date:  2006-07-24       Impact factor: 4.584

Review 3.  Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy.

Authors:  Allyson Lipp; Gail Lusardi
Journal:  Cochrane Database Syst Rev       Date:  2013-11-14

Review 4.  Senescent swallowing: impact, strategies, and interventions.

Authors:  Denise M Ney; Jennifer M Weiss; Amy J H Kind; JoAnne Robbins
Journal:  Nutr Clin Pract       Date:  2009 Jun-Jul       Impact factor: 3.080

5.  Indications for percutaneous endoscopic gastrostomy and survival in old adults.

Authors:  Anna Malmgren; Gunnel Wärn Hede; Brita Karlström; Tommy Cederholm; Per Lundquist; Mikael Wirén; Gerd Faxén-Irving
Journal:  Food Nutr Res       Date:  2011-07-20       Impact factor: 3.894

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.